Announcement of Shanghai Pharmaceuticals Group Co., Ltd. on holding the 2025 annual performance briefing meeting
Securities code: 601607 Securities abbreviation: Shanghai Pharmaceuticals Announcement number: Lin 2026-019
Shanghai Pharmaceutical Group Co., Ltd.
Announcement on Convening the 2025 Annual Performance Briefing Meeting
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: April 8, 2026 (Wednesday) 10:00-11:00
Meeting location: Shanghai Stock Exchange Roadshow Center (Website: https://roadshow.s seinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the Shanghai Securities Roadshow Center website before 16:00 on March 31, 2026 (Tuesday) to April 7 (Tuesday) and click on the "Question Pre-Collection" column to ask questions. The company will answer questions of common concern to investors at the briefing.
Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as the "Company") will release the company's 2025 annual report after the market closes on March 30, 2026. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2025 annual operating results and financial status, the company plans to hold the 2025 annual performance briefing on April 8, 2026 (Wednesday) from 10:00-11:00 to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an online interactive format. The company will interact and communicate with investors on the specific conditions of its operating results and financial indicators in 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: April 8, 2026 (Wednesday) 10:00-11:00
(2) Meeting location: Shanghai Securities Roadshow Center
(3) Meeting method: SSE Roadshow Center online interaction
3. Participants
Shen Bo Executive Director, President
Gu Chaoyang Independent Director
Zhou Yadong Vice President, Chief Financial Officer
Zhong Tao Vice President, Secretary of the Board of Directors
The above-mentioned participants will be adjusted according to the actual situation.
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 10:00-11:00 on April 8, 2026 (Wednesday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on March 31, 2026 (Tuesday), click on the "Pre-Call for Questions" column (https://road show.sseinfo.com/preCallQa), and select this event to ask questions to the company according to the event time. The company will answer questions of common concern to investors at the briefing session.
5. Contact person and consultation method
Contact: Board Office
Tel: 021-63557167
Email: [email protected]
6. Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
March 27, 2026